Patent · US Active

Tetrahydroisoquinoline derivatives

US10370355B2 · kind B2 · utility

1Cited by

0References

17Claims

0Family size

Assignee

UCB BIOPHARMA SRL · BE

Inventors

Ali Ates · Marbais, BE
Eric Jnoff · Brussels, BE
Laurent Provins · Soignies, BE
Anne Valade · Brussels, BE
Adrian Hall · Hatfield, GB

Key dates

Filing date	Apr 7, 2017
Grant date	Aug 6, 2019
Priority date	—
Expiry date	Apr 7, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to tetrahydroisoquinoline derivatives according to formula (I), wherein G represents a fused heterocyclic system selected from the groups represented by formula (G1), (G2), (G3), (G4), (G5), and (G6), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.